Exozymes (EXOZ) Current Assets (2023 - 2026)
Exozymes (EXOZ) posted quarterly Current Assets of $3.9 million for Q4 2025, down 63.59% year-over-year from $10.8 million in Q4 2024, and down 29.73% quarter-over-quarter from $5.6 million in Q3 2025.
Exozymes (EXOZ) Current Assets (2023 - 2026) Analysis & Trends
Exozymes (EXOZ) has reported Current Assets for 3 consecutive years, with $3.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets fell 63.59% year-over-year to $3.9 million; the TTM figure through Dec 2025 stood at $3.9 million (down 63.59% YoY), while the FY2025 annual figure was $3.9 million, down 63.59% from the prior year.
- Current Assets eased to $3.9 million in Q4 2025 per EXOZ's latest filing, from $5.6 million in the prior quarter.
- Across five years, Current Assets topped out at $10.8 million in Q4 2024 and bottomed at $1.2 million in Q4 2023.
- Historically, Current Assets has averaged $5.7 million across 3 years, with a median of $5.6 million in 2025.
- Annual changes were most pronounced in 2024 — Current Assets surged 791.58% — and 2025, when it plunged 63.59%.
- Exozymes' Current Assets stood at $1.2 million in 2023, then soared by 791.58% to $10.8 million in 2024, then slumped by 63.59% to $3.9 million in 2025.
- Business Quant data shows EXOZ's Current Assets at $3.9 million in Q4 2025, $5.6 million in Q3 2025, and $7.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - | 1.76 Bn |
| 10 | Exozymes | 65.09 Mn | 65.09 Mn | - | 6.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.17 Mn |
| Dec 31, 2025 | 3.94 Mn |
| Sep 30, 2025 | 5.61 Mn |
| Jun 30, 2025 | 7.53 Mn |
| Mar 31, 2025 | 9.42 Mn |
| Dec 31, 2024 | 10.82 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Dec 31, 2023 | 1.21 Mn |